AI-driven study reports identifying (Z)-endoxifen as a potential therapeutic candidate for glioblastoma
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…
FDA approves selumetinib for adults with neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas
On November 19, 2025, the Food and Drug Administration approved selumetinib for adults with neurofibromatosis…
FDA approves epcoritamab-bysp for follicular lymphoma indications
On November 18, 2025, the Food and Drug Administration approved epcoritamab-bysp with lenalidomide and rituximab for…
Antibody halts triple-negative breast cancer in preclinical models
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast…
ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome
A new national study shows for the first time that people exposed to Agent Orange…
SABCS 2025: First findings from a multi-year collaboration to advance AI-powered multimodal tools
Today at the San Antonio Breast Cancer Symposium (SABCS), researchers presented the initial findings from…
New gene-mapping method unlocks hidden drivers of cancer
University of South Australia scientists have developed a powerful new way to uncover the genetic…
Team discovers how to target ‘undruggable’ protein that fuels aggressive leukaemia
Researchers at the UCLA Health Jonsson Comprehensive Cancer Centre, USA, have identified a small molecule…
Prognostic tool could help clinicians identify high-risk cancer patients
Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very…